Muscular Dystrophy Canada’s ‘Walk & Roll’ events taking place in-person across Canada
For the first time since 2019, Muscular Dystrophy Canada (MDC) will host their annual ‘Walk & Roll for Muscular Dystrophy Canada’ event in person! This year, instead of hosting the event on one specific day nation-wide, Walk & Roll events will take place on different days from May to October at different locations in each province.
Sign up as an individual or with your clinical or research teams to attend one of the in-person events where you will meet patients, families, and other neuromuscular researchers and clinicians, all to raise awareness, funds, and support for the neuromuscular community.
Dates and times
- Montreal, QC | May 27th, 2023
- Edmonton, AB | June 3rd, 2023
- Ottawa, ON | June 11th, 2023
- Toronto, ON | June 24th, 2023
- Vancouver/Burnaby, BC | September 16th, 2023
- Calgary, AB | October 7th, 2023
If you don’t see your city, check out the full list of the 33 Walk & Roll events taking place across Canada to find your nearest event!
To learn more, please contact <>
Read next...
Hope on the Horizon: Trials, Treatments and Therapies for DMD, DM1 & MG
Nov 25-28, 2025 | Join us at Hope on the Horizon to learn more about the treatment and clinical trial landscape for Duchenne Muscular Dystrophy, Myotonic Dystrophy Type 1 and Myasthenia Gravis from key experts in the field!
2026 Awards Now Open for Nominations!
We’re proud to recognize outstanding achievements across the neuromuscular research community with our Three awards: Publication of the Year, Early Career Biomedical/Clinical Researchers of the Year.
A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada
Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.